Cortical Excitability and Role of rTMS in Cannabis Use Disorder
Primary Purpose
Cannabis Use Disorder, Moderate
Status
Unknown status
Phase
Early Phase 1
Locations
Study Type
Interventional
Intervention
rTMS
Sponsored by
About this trial
This is an interventional treatment trial for Cannabis Use Disorder, Moderate
Eligibility Criteria
Inclusion Criteria:
- 18to 50 years of age
- cannabis use disorder according to DSM 5 definition
- clear consent to participate in study
Exclusion Criteria:
- cardiac peacemaker
- metal implant in the head as participate will be applied to magnetic field of TMS
- current intake of any medication affect cognition (as anti psychotic and anti epileptic)
- current history of neurological , psychiatric or general medical disease .current or previous drug (other than cannabis )or alcohol abuse or participation in another trial during the past 8 weeks .
- age younger than 18 and older than 50 years
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Active Comparator
Arm Label
non cannabis addict
cannabis addict
Arm Description
30 non cannabis addict will be control group
30 cannabis addict will undergo rTMS
Outcomes
Primary Outcome Measures
Determination of role of rTMS for reducing cannabis craving
Incidenc of cannabis craving after rTMS
Secondary Outcome Measures
Estimation of cortical excitability in cannabis addict
Incidence of cannabis craving after cortical excitability
Full Information
NCT ID
NCT04106336
First Posted
September 23, 2019
Last Updated
September 25, 2019
Sponsor
Assiut University
1. Study Identification
Unique Protocol Identification Number
NCT04106336
Brief Title
Cortical Excitability and Role of rTMS in Cannabis Use Disorder
Official Title
Cortical Excitability and Role of rTMS in Cannabis Use Disorder
Study Type
Interventional
2. Study Status
Record Verification Date
September 2019
Overall Recruitment Status
Unknown status
Study Start Date
October 1, 2019 (Anticipated)
Primary Completion Date
October 1, 2020 (Anticipated)
Study Completion Date
December 30, 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Assiut University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Repetitive transcranial magnetic stimulation (rTMS) and cortical excitability have a role in cannabis use disorder
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cannabis Use Disorder, Moderate
7. Study Design
Primary Purpose
Treatment
Study Phase
Early Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
non cannabis addict
Arm Type
No Intervention
Arm Description
30 non cannabis addict will be control group
Arm Title
cannabis addict
Arm Type
Active Comparator
Arm Description
30 cannabis addict will undergo rTMS
Intervention Type
Device
Intervention Name(s)
rTMS
Intervention Description
Repetitive transcranial magnetic stimulation (rTMS) will be done for cannabis addict
Primary Outcome Measure Information:
Title
Determination of role of rTMS for reducing cannabis craving
Description
Incidenc of cannabis craving after rTMS
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Estimation of cortical excitability in cannabis addict
Description
Incidence of cannabis craving after cortical excitability
Time Frame
1 year
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
18to 50 years of age
cannabis use disorder according to DSM 5 definition
clear consent to participate in study
Exclusion Criteria:
cardiac peacemaker
metal implant in the head as participate will be applied to magnetic field of TMS
current intake of any medication affect cognition (as anti psychotic and anti epileptic)
current history of neurological , psychiatric or general medical disease .current or previous drug (other than cannabis )or alcohol abuse or participation in another trial during the past 8 weeks .
age younger than 18 and older than 50 years
12. IPD Sharing Statement
Learn more about this trial
Cortical Excitability and Role of rTMS in Cannabis Use Disorder
We'll reach out to this number within 24 hrs